Ratio Review: Analyzing Solid Biosciences Inc (SLDB)’s Price-to-Cash and Price-to-Free Cash Flow

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $6.30 in the prior trading day, Solid Biosciences Inc (NASDAQ: SLDB) closed at $6.46, up 2.54%. In other words, the price has increased by $2.54 from its previous closing price. On the day, 2.99 million shares were traded. SLDB stock price reached its highest trading level at $7.398 during the session, while it also had its lowest trading level at $6.11.

Ratios:

Our goal is to gain a better understanding of SLDB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.94 and its Current Ratio is at 14.94. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.

On March 28, 2024, William Blair started tracking the stock assigning a Outperform rating and target price of $40.

On March 15, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $16.Citigroup initiated its Buy rating on March 15, 2024, with a $16 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 07 ’24 when Kahn Clare bought 1,100 shares for $7.67 per share. The transaction valued at 8,442 led to the insider holds 1,100 shares of the business.

Ganot Ilan sold 462 shares of SLDB for $4,772 on May 02 ’24. The Director now owns 9,507 shares after completing the transaction at $10.33 per share. On Jan 29 ’24, another insider, Ganot Ilan, who serves as the Director of the company, sold 139 shares for $7.99 each. As a result, the insider received 1,111 and left with 8,416 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLDB now has a Market Capitalization of 247930928 and an Enterprise Value of 67681008.

Stock Price History:

Over the past 52 weeks, SLDB has reached a high of $15.05, while it has fallen to a 52-week low of $1.81. The 50-Day Moving Average of the stock is -27.12%, while the 200-Day Moving Average is calculated to be -4.82%.

Shares Statistics:

The stock has traded on average 219.59K shares per day over the past 3-months and 525260 shares per day over the last 10 days, according to various share statistics. A total of 38.38M shares are outstanding, with a floating share count of 32.59M. Insiders hold about 15.08% of the company’s shares, while institutions hold 78.12% stake in the company. Shares short for SLDB as of 1715731200 were 929238 with a Short Ratio of 3.83, compared to 1713139200 on 1049245. Therefore, it implies a Short% of Shares Outstanding of 929238 and a Short% of Float of 5.0300002.

Most Popular